Related Experiment Video

Updated: Sep 21, 2026

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis
12:19

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis

Published on: April 22, 2022

6-(p-hydroxyphenylazo)-uracil: a selective inhibitor of host DNA replication in phage-infected Bacillus subtilis

N C Brown

    Proceedings of the National Academy of Sciences of the United States of America
    |November 1, 1970
    PubMed

    Insights

    The azopyrimidine compound 6-(p-hydroxyphenylazo)-uracil selectively inhibits bacterial DNA replication without affecting other cellular processes. This drug specifically targets a host function essential for bacterial DNA synthesis.

    Area of Science:

    • Microbiology
    • Molecular Biology
    • Biochemistry

    Background:

    • Bacterial DNA replication is a critical target for antimicrobial agents.
    • Understanding selective inhibition mechanisms is key to developing new antibacterial therapies.

    Purpose of the Study:

    • To investigate the mechanism of action of the azopyrimidine compound 6-(p-hydroxyphenylazo)-uracil.
    • To determine the specificity of this compound's inhibitory effects on bacterial DNA replication.

    Main Methods:

    • Experiments were conducted on uninfected and phage-infected Bacillus subtilis.
    • The effects of 6-(p-hydroxyphenylazo)-uracil on DNA synthesis and other macromolecular metabolism were assessed.
    • Lysozyme treatment was used to assess the stability of the drug-sensitive host site.

    Main Results:

    • 6-(p-hydroxyphenylazo)-uracil selectively, completely, and reversibly inhibited bacterial DNA replication.
    • The compound showed no significant effects on the metabolism of other cellular macromolecules.
    • In phage-infected bacteria, viral DNA synthesis was unaffected, while host DNA synthesis was completely blocked.
    • The drug-sensitive host site remained sensitive even after partial cell disruption.

    Conclusions:

    • 6-(p-hydroxyphenylazo)-uracil acts as a specific inhibitor of a bacterial host function required for DNA replication.
    • This compound offers a potential avenue for developing targeted antibacterial agents that do not interfere with viral replication.

    More Related Videos

    Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi09:01

    Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi

    Published on: September 28, 2022

    T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo08:46

    T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo

    Published on: January 26, 2024

    Related Concept Videos

    DNA Base Pairing02:27

    DNA Base Pairing

    Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
    Viral Replication: Lytic Cycle01:20

    Viral Replication: Lytic Cycle

    Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
    DNA Bacteriophages01:26

    DNA Bacteriophages

    Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
    Inhibitors of Bacterial Protein Synthesis01:25

    Inhibitors of Bacterial Protein Synthesis

    Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
    Inhibitors of Bacterial DNA Synthesis01:28

    Inhibitors of Bacterial DNA Synthesis

    Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
    Antiviral Nucleoside Inhibitors01:22

    Antiviral Nucleoside Inhibitors

    Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...